Frontiers Effect of the serum 25-hydroxyvitamin D level on risk for short-term residual dizziness after successful repositioning in benign paroxysmal positional vertigo stratified by sex and onset age

ObjectiveA low serum 25-hydroxyvitamin D (25(OH)D) level is relevant to both the occurrence and recurrence of benign paroxysmal positional vertigo (BPPV). Ho

Frontiers in Neurology Neurological Biomarkers

Frontiers TGF-β based risk model to predict the prognosis and immune features in glioblastoma

Clinical Characteristics of Patients With Benign Paroxysmal Positional Vertigo Diagnosed Based on the Diagnostic Criteria of the Bárány Society. - Abstract - Europe PMC

Association between serum vitamin D levels and benign paroxysmal positional vertigo: a systematic review and meta-analysis of observational studies

Critical Care Nursing of the Oncology Patient [1 ed.] 9781635930153, 9781635930146

Serum 25-hydroxyvitamin D - List of Frontiers' open access articles

PDF) Mechanical rotational chair-assisted multiple canalith repositioning procedures for benign paroxysmal positional vertigo: enhanced vertigo relief, comparable adverse effects, and decreased incidence of residual dizziness

Seasonal variation of idiopathic benign paroxysmal positional vertigo correlates with serum 25-hydroxyvitamin D levels: a six-year registry study in Shanghai, China

Investigation of vitamin D status and its correlation with insulin resistance in a Chinese population, Public Health Nutrition

Relationship between serum 25 hydroxyvitamin D (25(OH)D) levels

Frontiers Low 25-Hydroxyvitamin D Levels Are Associated With Residual Dizziness After Successful Treatment of Benign Paroxysmal Positional Vertigo

PDF) Association Between Serum Uric Acid Levels and Benign Paroxysmal Positional Vertigo: A Systematic Review and Meta-Analysis of Observational Studies

Frontiers Correlation Between Benign Paroxysmal Positional Vertigo and 25-hydroxyvitamin D